Document Detail


Developmental and genetic aspects of atrial fibrillation.
MedLine Citation:
PMID:  19818948     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. The abnormal rhythm is associated not only with a variety of symptoms, such as palpitations, dizziness, or shortness of breath, but also with increased risk of stroke, heart failure, and mortality. A genetic predisposition is suggested by the fact that the relative risk for the development of AF is estimated at 85% in individuals with at least one parent with a history of AF. Current therapeutic strategies include control of rate or rhythm with medication and catheter ablation procedures. Especially in the pathophysiology of paroxysmal AF, ectopic electrical activity originating in the myocardial sleeves surrounding the pulmonary veins is considered causal. In these cases, ablation is applied to isolate the pulmonary venous myocardium from the remainder of the left atrial myocardium. Other recent evidence has shown that genetic and developmental defects can be involved in the development of AF. In this review, it is our aim to discuss the possible underlying causes of AF from a combined genetic and cardiac developmental view.
Authors:
Alex V Postma; Lukas R C Dekker; Alexandre T Soufan; Antoon F M Moorman
Related Documents :
9683908 - Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: i...
10654548 - Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment.
17315378 - Improvement of quality of life after percutaneous balloon mitral valvulotomy in patient...
14574038 - Atrial fibrillation: what are the targets for intervention?
16762798 - Temporal increases in subclinical levels of inflammation are associated with adverse cl...
12743668 - Left ventricular function and cardiovascular events following adjuvant therapy with ade...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Trends in cardiovascular medicine     Volume:  19     ISSN:  1873-2615     ISO Abbreviation:  Trends Cardiovasc. Med.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-10-12     Completed Date:  2009-12-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9108337     Medline TA:  Trends Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  123-30     Citation Subset:  IM    
Affiliation:
Heart Failure Research Center, Academic Medical Center, University of Amsterdam, The Netherlands. a.v.postma@amc.uva.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation / embryology,  etiology*,  genetics,  therapy
Atrial Function / genetics
Catheter Ablation
Gene Expression Regulation, Developmental
Genetic Predisposition to Disease
Genotype
Humans
Pedigree
Phenotype
Polymorphism, Genetic
Risk Assessment
Risk Factors
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Systems biology of vascular calcification.
Next Document:  Tetralogy of fallot as a model to study cardiac progenitor cell migration and differentiation during...